Tanimine, N.; Ohira, M.; Kurita, E.; Nakano, R.; Sakai, H.; Tahara, H.; Ide, K.; Kobayashi, T.; Tanaka, Y.; Ohdan, H.
Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation. Cancers 2024, 16, 533.
https://doi.org/10.3390/cancers16030533
AMA Style
Tanimine N, Ohira M, Kurita E, Nakano R, Sakai H, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H.
Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation. Cancers. 2024; 16(3):533.
https://doi.org/10.3390/cancers16030533
Chicago/Turabian Style
Tanimine, Naoki, Masahiro Ohira, Emi Kurita, Ryosuke Nakano, Hiroshi Sakai, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, and Hideki Ohdan.
2024. "Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation" Cancers 16, no. 3: 533.
https://doi.org/10.3390/cancers16030533
APA Style
Tanimine, N., Ohira, M., Kurita, E., Nakano, R., Sakai, H., Tahara, H., Ide, K., Kobayashi, T., Tanaka, Y., & Ohdan, H.
(2024). Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation. Cancers, 16(3), 533.
https://doi.org/10.3390/cancers16030533
